97 results
6-K
EX-99.1
BPTSY
Biophytis S.A.
20 Jun 24
Current report (foreign)
11:34am
and to exploring with them early market access opportunities for our most advanced indications. Together, we aim to deliver solutions to patients and physicians … access to medicines through partnerships with the Ministry of Health and official laboratories. Blanver is committed in always looking for innovations
6-K
EX-99.1
BPTSY
Biophytis S.A.
20 Jun 24
Biophytis extends its contract with Atlas to secure financing for its business activities
11:02am
for the specific respiratory symptoms is an opportunity for a fast access to market.
Biophytis is actively seeking partners and additional funding … framework
The securities issued will give Atlas access, immediately or in the future, to the Company's share capital, with cancellation of preferential
6-K
EX-99.1
BPTSY
Biophytis S.A.
7 Jun 24
Current report (foreign)
12:39pm
, including the voting form and the access map, are available on the Company's website (https://www.biophytis.com/en/action/assemblees-generales
6-K
EX-99.1
BPTSY
Biophytis S.A.
9 Apr 24
Biophytis announces its 2023 financial results
12:25pm
experiencing adverse events compared with placebo (57% vs. 64%).
Implementation of regulatory procedures to assess the conditions for market access … market.
2024: Reactivation of an early access programme in Brazil and extension to Europe. This strategy may be rolled out subject to regulatory
6-K
EX-99.1
eegtoz
22 Mar 24
Biophytis presented its phase 3 protocol in the treatment of sarcopenia
12:10pm
6-K
EX-99.1
z9kw03a
5 Jan 24
Biophytis announces the publication of the results of its COVA phase 2-3 study in eClinicalMedicine, part of The Lancet
12:11pm
6-K
EX-99.1
r7pa1ld8sr
21 Nov 23
Biophytis announces the success of its capital increase
10:29am
6-K
EX-99.1
6njth9f48w39lkgwrj
2 Nov 23
Biophytis and Innovation Solutions Pharma sign a partnership agreement to accelerate market access for Sarconeos (BIO101) in Brazil
2:44pm
6-K
jta yewi22su4stakfq6
2 Nov 23
Biophytis and Innovation Solutions Pharma sign a partnership agreement to accelerate market access for Sarconeos (BIO101) in Brazil
2:44pm
6-K
EX-99.1
qd5f04785ps7y ql4
23 Oct 23
Current report (foreign)
10:43am
6-K
EX-99.1
d140f
28 Sep 23
Current report (foreign)
10:18am
6-K
EX-99.1
fx7 x5fzhlt9sr0f
27 Sep 23
Half-year Financial Report
5:00pm
6-K
EX-99.1
l1abkkm5rdg54yjooe
20 Sep 23
Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19
6:02am
6-K
07sfnp72thf4mz5
20 Sep 23
Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19
6:02am
6-K
EX-99.1
lwu5 byaz8o3m
14 Sep 23
Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
11:03am
F-1
7tcwoxt2 bsgsgf
4 Aug 23
Registration statement (foreign)
4:18pm
F-1
EX-3.1
sdfo0jyhe5va
4 Aug 23
Registration statement (foreign)
4:18pm
6-K
EX-10.2
kf9 q0a5aajv4
21 Jul 23
Biophytis Announces $3.8 Million
6:01am
6-K
EX-10.1
vmszln
21 Jul 23
Biophytis Announces $3.8 Million
6:01am